August 30, 2001LORAZEPAM Tablets Recalled
Toledo, OH (SafetyAlerts) - The Food and
Drug Administration (FDA) said today that Heartland Repack Services,
is recalling LORAZEPAM Tablets, USP, 0.5mg, NDC #61392-455-39, packaged as
30 tablets per 'bingo' card, 140 cards per case.
This is the first public notice of
this Class II
recall issued by the FDA.
RECALL NUMBER, PRODUCT AND
Tablets, USP, 0.5mg, NDC #61392-455-39, packaged as 30 tablets per 'bingo'
card, 140 cards per case.
Lot Number: 18291 Exp Date: 5/31/2003
CONTAINER DEFECT; The plastic material used to repackage the individual
tablets is de-laminating.
Geneva Pharmaceuticals, Broomfield, CO
Heartland Repack Services, Toledo, OH, on 8/3/2001, by letter.
FIRM INITIATED RECALL:
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.